BOSTON, Apr 12, 2010 (BUSINESS WIRE) -- Orthofix International (NASDAQ: OFIX) announced today that its sports
medicine division, Breg, ranked 27th among businesses in
Mexico in the Great Place to Work(R) Institute's survey for
2010. The Breg Mexico facility, located in Mexicali, received top honors
for its positive culture and work environment. The facility's 2010
ranking was higher than its spot at #71 in 2009.
"This award is particularly meaningful to us because employee feedback
is the primary measurement in the survey," said Alan Milinazzo,
President and CEO of Orthofix. "We have worked hard throughout Orthofix
to create a positive culture that promotes innovation, collaboration and
success. We take great pride in our Mexicali facility, which exemplifies
this culture so well. The Mexicali team has created an exceptional work
environment where high-performing employees can feel valued, and have
the opportunity to excel personally and professionally."
Companies that appear on the Great Place to Work(R) list are
evaluated and selected based on employee responses to the Institute's
Trust Index(R) proprietary survey and Culture Audit(R)
questionnaire. Established in 1991, The Great Place to Work(R)
Institute provides Trust Assessments and produces Best Companies to Work
For lists in over 40 countries, surveying over 1.5 million employees
annually.
Breg, headquartered in Vista, CA, established its Mexico operations in
2002. The Mexicali facility employs 285 people who manufacturing all of
the company's cold therapy units and pads, off-the-shelf functional
braces, all soft goods and post-op braces. The Mexicali facility
manufactured and shipped over two million units in 2009. For more
information about Breg, visit www.breg.com.
About Orthofix
Orthofix International, N.V. is a global medical device company offering
a broad line of minimally invasive surgical, and non-surgical, products
for the spine, orthopedic, and sports medicine market sectors that
address the lifelong bone-and-joint health needs of patients of all
ages-helping them achieve a more active and mobile lifestyle. Orthofix's
products are widely distributed around the world to orthopedic surgeons
and patients via Orthofix's sales representatives and its subsidiaries,
including BREG, Inc. and via partnerships with other leading orthopedic
product companies. In addition, Orthofix is collaborating in R&D
partnerships with leading medical institutions such as the
Musculoskeletal Transplant Foundation, the Orthopedic Research and
Education Foundation, the University of Medicine and Dentistry of New
Jersey and the National Osteoporosis Institute. For more information
about Orthofix, please visit www.orthofix.com.
SOURCE: Orthofix International, N.V.
Orthofix International, N.V.
Dan Yarbrough, 617-912-2903
Vice President of Investor Relations
danyarbrough@orthofix.com
Copyright Business Wire 2010